EU Panel Backs Revolution Medicines’ Rasonque for Pancreatic Cancer
Revolution Medicines Rasonque gets a CHMP positive opinion for pretreated metastatic pancreatic cancer. FDA approved it in August. What comes next in the EU.
Tag: Rasonque EMA recommendation
Read More